GRANTS
Amylin is dedicated to improving lives through the discovery, development, and commercialization of innovative medicines for the treatment of diabetes and obesity.
The Amylin Grant Office (AGO) evaluates grant requests based on their merits and how well they align with our mission. Your grant request will receive a fair review; however, we are not able to approve every request. Please consider how your request aligns with our mission and scientific focus, and follow the guidelines for the type of grant you are requesting.
Please refer to the Grant Process section for additional information.
